Organization
LBSL02 Study Grp
1 abstract
Abstract
BELIMUMAB (BMAB), A FULLY HUMAN MONOCLONAL ANTIBODY TO B-LYMPHOCYTE STIMULATOR (BLYS), SHOWS BIOACTIVITY AND REDUCES SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITYOrg: LBSL02 Study Grp, Cedars-Sinai Comprehensive Cancer Center, UCLA Department of Medicine, Los Angeles Medical Center, UA AHSC,